The group of China Shipping Satellite TV walked to the administrative building with a smile. After arriving at the press room, I quickly found the location of Zhonghai Satellite TV. Several people walked over with their heads held high in the envious, jealous and hateful eyes of everyone.

"Hehe, it's so refreshing. It's the first time I've enjoyed this treatment. Speaking of which, I have the feeling that we are at the same level as CCTV. ”

Xiao Wang placed the camera and whispered. Some of the other colleagues felt the same way, and they all nodded tacitly.

The reason why China Shipping Satellite TV began to have such a special status on the side of Lingxian Group this year is naturally because of Xi Ya. Xi Ya transferred to China Shipping Satellite TV, and the leaders of China Shipping Satellite TV attached great importance to taking care of it, and Yang Guang naturally wanted to exchange courtesies.

In addition to sponsoring some programs, providing some convenience at the press conference of Lingxian Group is not worth mentioning.

After setting up the machine, Xiao Wang looked around curiously. The interior of this company can only be described as average. But look at the logos of many media suddenly soared, what CCTV, CNN and other internationally famous media gathered here.

It's really hard for those European and American media, after all, Yang Guang announced it last night, and it was announced at nine o'clock this morning. It's really capricious. I am afraid that media outlets such as CNN either have offices in China or have hastily transferred personnel from nearby countries.

At this time, the time has not yet come, and there is some noise in the press room, and the gathering of various languages is particularly lively.

"Good guys, this is no worse than the press conference of the Ministry of Defense or the Government Council." Xiao Wang looked around and said in a speechless manner.

"It's not that kind of Cheng dù yet. If Yang Guang and Lingxian Group can always surprise us as before, it is possible to develop in that direction. Speaking of which, there are few domestic companies that can have such an international influence. Lao Zhang said calmly.

As the time approached, the press conference hall gradually quieted down, and many media reporters waited for the start of the press conference. It was exactly nine o'clock. The side door opened, Jin Cheng appeared with a few people, and suddenly the magnesium light shone.

The photojournalist took the picture, but the others were a little regretful. Because Yang Guang did not appear, the reporters wanted to see Yang Guang's current state and ask him some questions. Who knew that today's occasion did not appear again, which can detract from the press conference. Immediately, the crowd cheered up.

"Thank you for joining us for attending this press conference. This is the first press conference since the establishment of Lingxian Biotechnology. On behalf of all the staff of Lingxian Biotech, I would like to express my gratitude for receiving such an enthusiastic response. Jin Cheng said on stage in standard Mandarin,

After speaking, Jin Cheng smiled, "I know that you must regret why our Chairman Yang didn't show up." Because Yang Dong doesn't want to dominate, the surprise to be announced today, that is, the products of Lingxian Biotechnology are destined to shock everyone. If Yang Dong appears, everyone will have no choice. At the same time, it will affect each other's limelight. So after thinking about it, Yang Dong handed over this glorious job to me. ”

Jin Cheng's words made everyone's already strong sense of expectation rise even higher.

Meantime. Just because of Jin Cheng, many media have realized Yang Guang's attention to this company. Jin Cheng's information is available in many media, and he knows that this is the person who began to follow Yang Guang very early, and he is also the head of Yang Guang's private think tank assistant team.

Moreover, the name Lingxian is the name of the group company, and it is actually used by this branch, which also reflects the importance of it.

"Biotechnology is multifaceted. The focus of Lingxian Biotech's development today is on medicine.

We all know that disease is the cruel enemy of humanity. Because the disease does not know how many tragedies are produced every year.

Despite the advancement of technology, the types of diseases are still endless. People are not just far from the threat of disease. There is even no cure for many conditions. It has brought great sadness and regret to many families. Kim Sung-seok said.

"For countless years, many colleagues in the medical field have been battling the disease. There are successes, there are failures, there are strengths and there are failures. Lingxian Group is now also joining this glorious industry. ”

Speaking of this, Jin Cheng looked at the reporters with different looks below, and a faint smile appeared on his face,

"As we all know, our Chairman Yang is now accustomed to making extraordinary moves. The same is true for the establishment of Lingxian Biotechnology this time. We did a lot of preparation. Yang Dong and many researchers have worked hard and worked a lot, and some achievements have been born. One of those is the focus of today's release. ”

At this time, there was some discussion below. Since yesterday, some people have speculated that Yang Guang's surprise was a drug, and now it has been confirmed. can make Yang Guang so solemn, and immediately people have a guess about what kind of disease this drug treats.

"That's right. Just as everyone guessed. As we all know, human medical technology is particularly powerless in the face of some diseases. We call those conditions terminal illnesses. Although medical advances have made some terminal illnesses treated, there is still a problem of chance. Especially if the illness is too severe, the treatment is more like a delay. Jin Cheng said loudly,

"This time, the scientists in the room completely solved a terminal illness. This terminal illness is leukemia. ”

Even if there was some speculation before, everyone was still in an uproar when they heard Jin Cheng's real announcement.

That's a terminal illness. I don't know how many people can only wait for death if they get it. Even if the family has money and spends a lot of money, the results are not necessarily satisfactory. It is similar to leukemia, although there is a more effective method of transplanting bone marrow. But not to mention that the right bone marrow is hard to find. Even if a suitable bone marrow can be transplanted, some people still can't get rid of the drug, and it is not a real cure.

The name given to this drug is Guangjiake, which is the joint name of Yang Dong and two scientists who have made outstanding contributions. This drug has undergone various tests and completed clinical trials. The results are outstanding.

No surgery, no special treatments. You just need to take the medicine according to the course of treatment. By the way, this drug is said to taste pretty good.

In the early and middle stages, only four to six courses are required to fully recover. In the later stage, it is necessary to increase the dose, about eight courses of complete recovery. It may also require enhanced nutrition and blood replenishment. But these are problems that can be easily solved. ”

At this time, many reporters in the audience raised their hands one after another, and some even asked questions directly.

Jin Cheng tapped the microphone and suppressed the noise, "Okay, I know you guys have a lot of questions, but wait for me to finish first, okay?" ”

The press conference hall fell silent, Jin Cheng nodded with satisfaction, and continued,

"The price of Guangjiake is not expensive, and the total cost after the treatment is completed is about 5,000 yuan to 30,000 yuan. Lingxian Biotechnology has discussed with the Government Council and the Ministry of Health, and Guangjiake will be added to the list of drugs covered by medical insurance. If the family situation is really difficult and still cannot afford it. Please contact Benevolence Charitable Foundation. In short, our request for Chairman Yang is that we will never see a single tragedy caused by leukemia in Huaxia.

The way to buy drugs is very simple, they can be purchased in public hospitals in various prefecture-level cities in China, and they can be used there according to the doctor's instructions. In the future, the drug will be rolled out to county hospitals. In short, it is convenient for all patients to seek medical treatment. ”

At this time, I don't know how many people are paying attention to this press conference. Especially after Jin Cheng said that the leukemia was completely solved, many online media have spread the news, and even some TV stations have begun to insert the news. Various smart programs are starting to promote this news.

Immediately, the attention was greatly increased.

Terminal illness is the most vicious enemy of mankind, and it is said that the solution of a terminal illness is a major event for all mankind to cheer about.

Of course, the capitalists, who produce drugs for leukemia and receive a lot of profit from them, will not be happy to hear this.

I don't know how many people shouted Lingxian Biotechnology and the Amazing Solid Yàn Room and even Yang Guang's strength. But there are also people who feel that something is wrong, especially people abroad, who are awkward when they look at the news.

Yang Guang's quality is undoubtedly admirable, and everyone knows how huge the R&D cost is needed to overcome terminal diseases. Many of the drugs available to treat leukemia on the market today are expensive. Even some relatively inexpensive drugs are maintenance drugs that cannot be cured.

This kind of drug that can be completely cured is so cheap, it can be said that it is a loss price. It is estimated that the most is added to the cost of drug production. As for the higher R&D costs, there is no mention of it. This quality and sentiment is undoubtedly admirable.

What's awkward is that Jin Cheng's words only mention Huaxia, so where can foreign patients go to buy?

Jin Cheng didn't seem to know the doubts and grievances of others.

"This is a gift from Chairman Yang and all our staff to all mankind. But Lingxian Biotechnology is not just this achievement. Originally, the room was going to overcome all the terminal diseases, but later it turned out that this was not realistic, and it required too much energy and time. Also not cost-effective.

It's not that we don't pay attention to the treatment of other terminal diseases, but we consider it comprehensively. Although the terminal illness is terrible, there are still very few people in the whole world who really suffer such fate. On the contrary, more diseases that plague too many people are worth more energy. For example, cardiovascular and cerebrovascular diseases and so on.

Naturally, for the study of terminal diseases, the stinging room is still ongoing. When needed, we will increase the power of investment. It depends on future developments. ”

Jin Cheng's statement, the audience and the audience did not know whether to agree or oppose...... (To be continued......)